Citations 8

On the Way to Mars: Navigating the Possible Impacts of Cosmic Radiation on Leukemia Risk

IAF/IAA Space Life Sciences Symposium | January 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: 579-581

10.52202/083074-0075

Space-Based Stem Cell Research and Its Potential for Transforming Earthbound Cellular Therapies

IAF/IAA Space Life Sciences Symposium | January 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: 177-180

10.52202/083074-0027

Development of the New Zealand Space Health Research Network

IAF/IAA Space Life Sciences Symposium | January 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: 155-157

10.52202/083074-0022

Sustaining Human Health in Spaceflight - Ethical Challenges

IAF/IAA Space Life Sciences Symposium | January 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: 128-132

10.52202/083074-0017

EGFR mRNA-Engineered Mesenchymal Stem Cells (MSCs) Demonstrate Radioresistance to Moderate Dose of Simulated Cosmic Radiation

Cells | November 3, 2025 | Volume: 14 | Issue: 21 | Pages: 1719

10.3390/cells14211719 | PMID 41227364

Galactic cosmic ray (GCR) radiation is a major barrier to human space exploration beyond Earth’s magnetic field protection. Mesenchymal stem cells (MSCs) are found in all organs and play a critical role in repair and regeneration of tissue. We engineered bone marrow-derived MSCs and evaluated their response to ionizing radiation exposure. Epidermal growth factor receptor (EGFR) expression by certain types of cancers has been shown to induce radioresistance. In this study, we tested the feasibility of transfecting MSCs to overexpress EGFR (eMSC-EGFR) and their capacity to tolerate and recover from X-ray exposure. Quantitative real-time PCR (qRT-PCR) and immunoblotting results confirmed the efficient transfection of EGFR into MSCs and EGFR protein production. eMSC-EGFR maintained characteristics of human MSCs as outlined by the International Society for Cell & Gene Therapy. Then, engineered MSCs were exposed to various dose rates of X-ray (1–20 Gy) to assess the potential radioprotective role of EGFR overexpression in MSCs. Post-irradiation analysis included evaluation of morphology, cell proliferation, viability, tumorigenic potential, and DNA damage. eMSC-EGFR showed signs of radioresistance compared to naïve MSCs when assessing relative proliferation one week following exposure to 1–8 Gy X-rays, and significantly lower DNA damage content 24 h after exposure to 4 Gy. We establish for the first time the efficient generation of EGFR overexpressing MSCs as a model for enhancing the human body to tolerate and recover from moderate dose radiation injury in long-term manned space travel.
The Development and Formation of Blood Malignancies in Astronauts and Space Travelers as a Result of Cosmic Radiation During Deep Space Travel

IAF/IAA Space Life Sciences Symposium | January 31, 2025 | Volume: No volume available | Issue: No issue available | Pages: 649-654

10.52202/078355-0084

Engineered Stem Cells and the Spaceflight Environment: What Happens When Exposed to Cosmic Radiation?

IAF/IAA Space Life Sciences Symposium | January 31, 2025 | Volume: No volume available | Issue: No issue available | Pages: 323-327

10.52202/078355-0039

New Zealand's Place in Space: An Emerging Space Nation in the Pacific Ocean Heading Towards the Cosmos

IAF Symposium on Emerging Space Ecosystems | January 31, 2025 | Volume: No volume available | Issue: No issue available | Pages: 163-169

10.52202/078388-0019